Abbott: Abbott Laboratories Reports Earnings Results for the First Quarter Ended March 31, 2025

Abbott Laboratories reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 10,358 million compared to USD 9,964 million a year ago. Net income was USD 1,325 million compared to USD 1,225 million a year ago. Diluted earnings per share from continuing operations was USD 0.76 compared to USD 0.7 a year ago. Abbott Laboratories reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 10,358 million compared to USD 9,964 million a year ago. Net income was USD 1,325 million compared to USD 1,225 million a year ago. Diluted earnings per share from continuing operations was USD 0.76 compared to USD 0.7 a year ago.